Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staging prostate cancer.

R F Hoedemaeker1, A N Vis, T H Van Der Kwast

  • 1Department of Pathology, Erasmus University, 3000 DR Rotterdam, The Netherlands. Hoedemaeker@path.fgg.eur.nl

Microscopy Research and Technique
|November 14, 2000
PubMed
Summary

The TNM staging system for prostate cancer requires updates. Current clinical staging often underestimates tumor extent, necessitating improved tools for accurate patient management and treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncological outcomes following PSMA PET/CT-guided salvage whole-pelvis radiotherapy for recurrent prostate cancer.

Clinical and translational radiation oncology·2026
Same author

Higher Preoperative Maximum Standardised Uptake Values Are Associated with a Higher Risk of Metastases After Robot-assisted Radical Prostatectomy for Patients Undergoing <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computed Tomography.

European urology oncology·2025
Same author

Histopathological concordance between prostate biopsies and radical prostatectomy specimens-implications of transrectal and transperineal biopsy approaches.

Prostate cancer and prostatic diseases·2023
Same author

A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and <sup>18</sup>F-PSMA-PET/CT.

Urologic oncology·2023
Same author

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial.

BMC cancer·2021
Same author

Determining the diagnostic value of PSMA-PET/CT imaging in patients with persistent high prostate specific antigen levels and negative prostate biopsies.

Urologic oncology·2021

Area of Science:

  • Oncology
  • Urology

Background:

  • Tumor staging systematically describes cancer extent.
  • The TNM (tumor, lymph node, metastasis) system is globally used for prostate cancer staging.

Purpose of the Study:

  • To review the current TNM staging system for prostate cancer.
  • To identify limitations and areas for improvement in prostate cancer staging.

Main Methods:

  • Discussion of the TNM system's clinical and pathological staging criteria.
  • Analysis of specific criteria including extraprostatic extension, seminal vesicle invasion, and bladder neck invasion.
  • Review of follow-up data from 123 radical prostatectomy patients.

Main Results:

  • Prostate tumors are clinically understaged in over half of cases.
  • Current TNM system criteria for pathological staging are sometimes unclear.
  • Multifocal tumors, common in prostate cancer, are not addressed in the current system.
  • Reporting of seminal vesicle and bladder neck invasion is crucial based on patient data.

Conclusions:

  • The TNM staging system for prostate cancer needs refinement.
  • Additional clinical tools are required for accurate staging and treatment planning.
  • Clarification of staging criteria and inclusion of factors like multifocality are essential for precise pathological assessment.

Related Experiment Videos